AnimalResearch is an essential part of the drug discovery process - they help us test new treatments, and could help change ...

A study that compared the gene expression profile of Alzheimer's disease with those triggered by 1,300 approved drugs identified a combination of two cancer medications as a potential treatment for ...

Researchers have found that a pair of drugs can not only slow down Alzheimer’s disease but actually reverse it and restore memory in mice.

Study harnesses a cell-type-specific, multi-target drug discovery strategy grounded in human data and real-world evidence.

The four clusters were mental health (psychiatric conditions), encephalopathy (brain dysfunctions that gradually get worse), ...

UCSF researchers find that two FDA-approved cancer drugs significantly improve memory in Alzheimer’s mouse models and reduce ...

UCSF researchers found the cancer drugs letrozole and irinotecan may reverse Alzheimer's effects, reducing tau protein clumps ...

Li, Huang, and Sirota chose 2 cancer drugs out of the top 5 drug candidates for laboratory testing. They predicted one drug, ...

A group of researchers in the lab of Prof. Lucía Chávez Gutiérrez (VIB-KU Leuven) has unraveled the genetic contributions to familial Alzheimer's Disease development and revealed how specific ...

In 2019, the worldwide cost of dementia was estimated at $1.3 trillion, a figure projected to rise to $2.8 trillion by 2030, according to Alzheimer's Disease International.